304 related articles for article (PubMed ID: 21953617)
1. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience.
Laurenti L; Tarnani M; Nichele I; Ciolli S; Cortelezzi A; Forconi F; Rossi D; Mauro FR; D'Arena G; Del Poeta G; Montanaro M; Morabito F; Musolino C; Callea V; Falchi L; Tedeschi A; Ambrosetti A; Gaidano G; Leone G; Foà R
Am J Hematol; 2011 Dec; 86(12):1007-12. PubMed ID: 21953617
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis.
Xu W; Li JY; Wu YJ; Cao X; Fan L; Qiao C; Liu Q; Yao L; Miao KR
Leuk Res; 2009 Dec; 33(12):1619-22. PubMed ID: 19250675
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms.
Vannucchi AM; Masala G; Antonioli E; Chiara Susini M; Guglielmelli P; Pieri L; Maggi L; Caini S; Palli D; Bogani C; Ponziani V; Pancrazzi A; Annunziato F; Bosi A
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2068-73. PubMed ID: 19531676
[TBL] [Abstract][Full Text] [Related]
4. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.
Robertson LE; Estey E; Kantarjian H; Koller C; O'Brien S; Brown B; Keating MJ
Leukemia; 1994 Dec; 8(12):2047-51. PubMed ID: 7807993
[TBL] [Abstract][Full Text] [Related]
5. [Synchronous and metachronous myeloid and lymphoid tumors].
Melikian AL; Kolosheĭnova TI; Goriacheva SR; Subortseva IN; Vakhrusheva MV; Kolosova EN; Sudarikov AB; Abdullaev AO; Dvirnyk VN; Varlamova EIu; Kovrigina AM; Turkina AG
Ter Arkh; 2014; 86(7):37-44. PubMed ID: 25314776
[TBL] [Abstract][Full Text] [Related]
6. The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia.
Parekh K; Rusch V; Kris M
Cancer; 1999 Nov; 86(9):1720-3. PubMed ID: 10547544
[TBL] [Abstract][Full Text] [Related]
7. PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature.
Paydas S; Tanriverdi K; Yavuz S; Seydaoglu G
Leuk Res; 2007 Mar; 31(3):365-9. PubMed ID: 16914202
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
9. CD5 negative lymphocytosis mimicking typical B-chronic lymphocytic leukaemia. Description of 26 cases.
De Rossi G; Mauro FR; Lo Coco F; Caruso R; Niscola P; Pasqualetti D; Mandelli F
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):451-5. PubMed ID: 7692397
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
Rawstron AC; Bennett FL; O'Connor SJ; Kwok M; Fenton JA; Plummer M; de Tute R; Owen RG; Richards SJ; Jack AS; Hillmen P
N Engl J Med; 2008 Aug; 359(6):575-83. PubMed ID: 18687638
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics.
Todisco G; Manshouri T; Verstovsek S; Masarova L; Pierce SA; Keating MJ; Estrov Z
Leuk Lymphoma; 2016 May; 57(5):1054-9. PubMed ID: 26402369
[TBL] [Abstract][Full Text] [Related]
12. Natural history of early chronic lymphocytic leukemia. A single institution study with emphasis on the impact of disease-progression on overall survival.
Molica S; Levato D; Dattilo A
Haematologica; 1999 Dec; 84(12):1094-9. PubMed ID: 10586211
[TBL] [Abstract][Full Text] [Related]
13. Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.
Bairey O; Ruchlemer R; Rahimi-Levene N; Herishanu Y; Braester A; Berrebi A; Polliack A; Klepfish A; Shvidel L;
Ann Hematol; 2011 Oct; 90(10):1123-9. PubMed ID: 21614458
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D insufficiency in myeloproliferative neoplasms and myelodysplastic syndromes: clinical correlates and prognostic studies.
Pardanani A; Drake MT; Finke C; Lasho TL; Rozell SA; Jimma T; Tefferi A
Am J Hematol; 2011 Dec; 86(12):1013-6. PubMed ID: 22086864
[TBL] [Abstract][Full Text] [Related]
15. Leukemia incidence following primary breast carcinoma treatment.
Kaplan HG; Malmgren JA; Atwood M
Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478
[TBL] [Abstract][Full Text] [Related]
16. What is changing in the natural history of chronic lymphocytic leukemia?
Molica S; Levato D
Haematologica; 2001 Jan; 86(1):8-12. PubMed ID: 11146563
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
[TBL] [Abstract][Full Text] [Related]
18. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
19. [A case of chronic myeloid leukemia occurring during treatment for chronic lymphocytic leukemia].
Hattori H; Kuwayama M; Kotake T; Karasuno T
Gan To Kagaku Ryoho; 2011 Feb; 38(2):333-6. PubMed ID: 21368508
[TBL] [Abstract][Full Text] [Related]
20. JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN).
Kodali S; Chen C; Rathnasabapathy C; Wang JC
Leuk Res; 2009 Dec; 33(12):e236-9. PubMed ID: 19625083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
